# The Role of Short-course Ceftriaxone Therapy in the Treatment of Severe Nontyphoidal Salmonella Enterocolitis

> **NCT01278017** · PHASE4 · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Diarrhea

## Interventions

- **DRUG:** ceftriaxone

## Key facts

- **NCT ID:** NCT01278017
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-08
- **Primary completion:** 2011-06
- **Final completion:** 2012-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2011-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01278017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01278017, "The Role of Short-course Ceftriaxone Therapy in the Treatment of Severe Nontyphoidal Salmonella Enterocolitis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01278017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*